COVID-19
Developing new therapies and getting them to patients is long and difficult. During public health emergencies, such as the Covid-19 Pandemic, science must move faster than ever. That is where translational science comes in. Translational science is focused on streamlining the process of moving (“translating”) lab findings into medical practice and treatments to improve health and well-being.
NCATS is supporting research activities spanning the translational science spectrum to address the novel coronavirus 2019 (SARS-CoV-2) and the disease it causes (COVID-19). To accelerate translational research, NCATS has developed research tools, technologies, expertise and collaborative networks that can quickly pivot to address urgent public health issues.
- Image
Columbia University
The mission of the Irving Institute for Clinical and Translational Research is to advance discoveries, knowledge, and innovation to improve human health across the lifespan for diverse populations in upper Manhattan and around the world. By mobilizing and connecting Columbia University’s researchers, we aim to create a seamless integration of community and academic partnerships. Our commitment to train a multi-faceted workforce, provide vital resources to researchers, and improve the efficiency of research processes, promotes the collaborative team science framework needed to translate research discoveries into effective interventions that address current and future health concerns.
We provide over 70 different services and programs focused on education and training, seed funding, bioinformatics, biostatistics, clinical research, lifespan research and special populations, regulatory knowledge and bioethics, an off-site community facility and health informatics websites. 
June 08, 2022The COVID-19 pandemic continues to present considerable public health challenges in the United States and around the globe. One of the most puzzling is why many people who get over an initial and often relatively mild COVID illness later develop new and potentially debilitating symptoms. These symptoms run the gamut including fatigue, shortness of breath, brain fog, anxiety, and gastrointestinal
June 06, 2022Episode Summary Early in the pandemic, Claire Decoteau, Iván Arenas their robust team of interdisciplinary researchers began to interview Black, Latinx, and white residents of three Chicago neighborhoods in order to explore how the pandemic has impacted different communities. Drawing on over 150 interviews with residents and policy makers, the team found that while COVID-19 has been treated as a
June 03, 2022A large randomized, placebo-controlled clinical trial led by the National Institutes of Health shows that treating adults hospitalized with COVID-19 with infliximab or abatacept — drugs widely used to treat certain autoimmune diseases — did not significantly shorten time to recovery but did substantially improve clinical status and reduce deaths. Some COVID-19 patients experience an immune
May 26, 2022SDoH are the non-clinical covariates of how people live, grow, learn and age and relates to how people manage stressors or prevent worsening health outcomes. Progressively, data about patient-level SDoH are collected using clinical screening tools for social needs and social risk factors. CD2H has led multiple SDoH synergistic initiatives relating to overall improvement of SDoH encoding and
-Pennsylvania State Univ Hershey Med CtrIn this seminar, Mary Frecker, PhD, and Greg Lewis, PhD, director and associate director of Penn State Center for Biodevices, will describe the Center’s approach toward fostering multidisciplinary research collaborations and the recommendations of a University-wide panel they have hosted on this topic. This seminar is for researchers interested in learning about cross-campus interdisciplinary
May 18, 2022Washington University School of Medicine in St. Louis has received a $61 million grant from the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) to support the infrastructure for developing and carrying out biomedical research studies. The funding supports Washington University’s Institute of Clinical and Translational Sciences (ICTS), which was
May 06, 2022Congratulations to Sara Auld, MD, MSc, who received the Albert E. Levy Award for Excellence in Scientific Research, junior faculty at Emory University. “I am so grateful for the wonderful colleagues and mentors I have had the pleasure of working with over the last several years,” says Dr. Auld. “As the saying goes, ‘chance favors the prepared,’ and my MSCR training allowed me to be prepared to
May 02, 2022As COVID-19 vaccines are approved for pediatric populations, a cross-collaborative effort between the USC School of Cinematic Arts, the Annenberg School for Communication and Journalism, and the Keck School of Medicine seeks to highlight the importance of getting vaccinated to protect yourself and your family. This successful collaboration resulted in the creation, production and dissemination of
April 29, 2022Assefa, a recent graduate of UVA, participated in the UVA-Historically Black Colleges and Universities Summer Research Bridge to Data Science program (Bridge) as a research fellow. This program is co-sponsored by integrated Translational Health Research Institute of Virginia (iTHRIV), the UVA School of Data Science (UVA SDS), Oracle, and Deloitte. According to the UVA SDS, the UVA-HBCU Summer
April 28, 2022Since 2007, the Institute of Translational Health Sciences (ITHS) has partnered with the University of Washington (UW), Fred Hutchinson Cancer Research Center, and Seattle Children’s on a Clinical and Translational Science Award (CTSA). This hub serves a large five-state region—Washington, Wyoming, Alaska, Montana, and Idaho (WWAMI)—encompassing rural and urban communities with unique health
April 28, 2022With hundreds of participating institutions—including all CTSA hubs—SMART IRB continues to facilitate reliance for multisite studies across the U.S., including more than 300 studies related to COVID-19. Investigators, study teams, and administrators at both reviewing and relying institutions can review the SMART IRB Agreement and access free resources on our website (www.smartirb.org). Next up
-Children's Research InstituteRegistration is now open for the 5th Annual Children's National Hospital - NIAD Symposium! The two-day hybrid symposium will feature current research related to COVID-19 and Autoinflammatory/Neuroimmune. All are invited to attend! This annual symposium celebrates the partnership between Children’s National Hospital and the National Institute of Allergy and Infectious Diseases (NIAID). Established
April 15, 2022A University of Arkansas for Medical Sciences (UAMS) team’s article on COVID-19 vaccine hesitancy recently received the 2022 Clinical and Translational Science Award from the American Society for Clinical Pharmacology & Therapeutics (ASCPT). The study, “COVID-19 Vaccine Hesitancy: Race/Ethnicity, Trust and Fear,” became the most downloaded paper in 2021 from ASCPT’s journal Clinical and
-University Of Miami School Of MedicineThe disruptions to social and economic life related to the COVID-19 pandemic have exacerbated factors known to elevate the risk of intimate partner violence (IPV) and created barriers to service availability for women currently experiencing it. This binational program of research comprised of scientists and community partners from Toronto, Chicago, and Miami helps address an ongoing need for
The Rapid Research Pilot Program (RP2) is designed to provide support for small, manageable research studies that focus on evaluating novel strategies for the implementation of COVID-19 testing in vulnerable and underserved populations. Researchers seeking funds to conduct COVID-19 testing can apply for up to $200,000 in direct cost funding and, if awarded, will have one year to complete the co
April 04, 2022Vanderbilt University Medical Center has competed successfully for a third five-year renewal of its Clinical and Translational Science (UL1) Award by the National Center for Advancing Translational Sciences. Initially funded in 2007, the renewal will provide more than $73 million for another five years to support the Vanderbilt Institute for Clinical and Translational Research (VICTR) and its
March 30, 2022The National Center for Data to Health’s National COVID Cohort Collaborative (N3C) Data Enclave houses the largest repository of COVID-19 data in the United States, with more than 4.5 million COVID+ patients. The N3C Data Enclave contains harmonized clinical data provided by more than 70 contributing health care institutions and consists of more than 14 billion rows of clinical information. The
March 08, 2022A new study published in the Journal of Infectious Diseases and led by Martin Zand, M.D., Ph.D., co-director of the University of Rochester Clinical and Translational Science Institute, shows that pre-existing immunity to the common cold may have put people at risk of more severe COVID illness and death. The study utilized the UR CTSI’s COVID Biobank to analyze antibodies in blood samples from
March 08, 2022Rochelle P. Walensky, MD, MPH, director of the Centers for Disease Control and Prevention (CDC), visited Washington University School of Medicine to discuss lessons learned from the COVID-19 pandemic. As part of the Department of Medicine’s weekly Grand Rounds series, she sat down with ICTS Director William G. Powderly, MD for a discussion that highlighted the pandemic’s success stories and
February 28, 2022Five recent publications from the National COVID Cohort Collaborative's (N3C) Immunosuppressed/Compromised Domain Team highlight the increased risk COVID-19 poses to people with immunocompromising diseases (such as HIV and rheumatoid arthritis) and organ transplant recipients. The international team of researchers collaborated with other N3C Domain Teams, including the Pharmacoepi and COVID-19
February 24, 2022A consortium among Minnesota health-care providers, organizations, and the University of Minnesota designed to use electronic health record data for research and quality improvement quickly shifted into a vital surveillance tool in tracking the COVID-19 pandemic.
-Emory UniversityJoin us March 3-4, 2022, at Callaway Resort and Gardens as we bring together researchers from across the region to present the best new health-related preclinical, clinical, implementation, and population-based research and build collaborative relationships. Featured talks Concurrent breakout sessions focused on rural health, COVID-19, health service delivery, health equity, development of
February 17, 2022Public health experts report that members of immigrant and refugee communities continue to be disproportionately affected by the COVID-19 pandemic, with higher rates of infection and death. Health disparities can be associated with job type, immigration status and English proficiency. A team of Mayo Clinic medical experts and community leaders collaborated to find ways to reduce health disparities
February 09, 2022The National Institutes of Health (NIH) has invested nearly $470 million to build a national study population of diverse research volunteers and support large-scale studies on the long-term effects of COVID-19. The Colorado Clinical and Translational Sciences Institute (CCTSI) is playing a major role in the initiative called REsearching COVID to Enhance Recovery or RECOVER. Many of us know someone
February 08, 2022A new article by researchers at the Medical University of South Carolina (MUSC) and Clemson University in the Journal of Medical Internet Research (JMIR) Research Protocols provides a roadmap for implementing an exposure notification mobile app among students, faculty and staff at Clemson, a large public university in South Carolina. The roadmap also provides a theory-based framework for
February 01, 2022Insights to Inspire 2022: In Our Own Words is a collection of Program Summaries from across the consortium for the Careers in Clinical & Translational Research (CCTR) metric. From 36 unique hubs come insights into how hubs are working to improve the experiences of their KL2 scholars and TL1 trainees. Starting in December 2021 and extending through April 2022, In Our Own Words will feature one of
January 25, 2022LITTLE ROCK — A University of Arkansas for Medical Sciences (UAMS) research team has found that while the coronavirus can create dangerous variants like delta and omicron, its ability to mutate has limits that should help drug and vaccine makers trying to thwart it. Drawing from global databases with millions of sequenced SARS-CoV-2 genomes, the multinational team, led by David Ussery, Ph.D., has
January 13, 2022At this point in the pandemic, you or someone you know has probably received at least one COVID-19 test. But do you know which kind of test you got and the strengths and weaknesses of these different tests?
January 12, 2022University of Florida faculty are leading a multistate team to boost COVID-19 and influenza vaccination rates in parts of the country where health care skepticism is common and vaccination rates are low. With the emergence of the highly contagious omicron COVID-19 variant, experts say it is more important than ever to provide people with information and access to protective vaccines. The Our
